BIOMAT Database Logo BIOMAT Database Logo

[The fibrillarin (Scl-34) autoantibody in systemic scleroderma]. 1990

G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Hautklinik, Medizinischen Akademie Warschau.

Reexamination of ANA positive sera with nucleolare fluorescence staining on HEp-2 cells and hamster liver imprints revealed 3 sera with an uniform characteristic pattern. It is characterized by: 1. Strong clumpy fluorescence of nucleoli in the interphase. 2. Missing nucleoplasma staining (pure nucleolar). 3. Characteristic granular staining of the cytoplasma from the condensed chromosoma in mitosis. 4. Additive fluorescence of a nucleolus-like body. 5. Extremely high antibody titers. 6. Negative immunodiffusion. This nucleolar staining pattern was described by Bernstein et al. as a clumpy nucleolar pattern. It is produced through an antibody to the dense fibrillar component of the nucleolus (fibrillarin). This antigen is a protein of the U3 RNP with a molecular weight 34 kDa. Clinically is the fibrillarin antibody highly specific for systemic scleroderma especially with diffuse skin involvement. We found it in 1% of scleroderma patients. Its pathogenetic importance is not known.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002466 Cell Nucleolus Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed) Plasmosome,Cell Nucleoli,Nucleoli, Cell,Nucleolus, Cell,Plasmosomes
D002868 Chromosomal Proteins, Non-Histone Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. Non-Histone Chromosomal Proteins,Chromosomal Proteins, Non Histone,Chromosomal Proteins, Nonhistone,Non-Histone Chromosomal Phosphoproteins,Chromosomal Phosphoproteins, Non-Histone,Non Histone Chromosomal Phosphoproteins,Non Histone Chromosomal Proteins,Nonhistone Chromosomal Proteins,Proteins, Non-Histone Chromosomal
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
[Anti-Scl-70 antibodies in systemic scleroderma].
January 1990, Annales de dermatologie et de venereologie,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis.
January 1992, Arthritis and rheumatism,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
PM-SCL autoantibody positive scleroderma with polymyositis (mechanic's hand: clinical aid in the diagnosis).
May 2004, Journal of the European Academy of Dermatology and Venereology : JEADV,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.
July 1996, Arthritis and rheumatism,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies.
October 2019, Kidney international reports,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Cyclosporine therapy for severe systemic sclerosis associated with the anti-Scl-70 autoantibody.
April 1990, Journal of the American Academy of Dermatology,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
[Anticentromere and anti-Scl-70 antibodies as specific markers of systemic scleroderma].
January 1986, Przeglad dermatologiczny,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
May 2010, Clinica chimica acta; international journal of clinical chemistry,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays.
July 2021, Clinical rheumatology,
G Kühn, and M Jarzabek-Chorzelska, and M Blaszczyk, and T P Chorzelski, and S Jablonska
Fibrillarin antibodies in systemic sclerosis.
June 2022, Archives of rheumatology,
Copied contents to your clipboard!